Basel, Switzerland

Andre Furlenmeier


Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • Basle, CH (1987 - 1991)
  • Basel, CH (1976 - 1995)

Company Filing History:


Years Active: 1976-1995

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Mind of Andre Furlenmeier

Introduction:

Andre Furlenmeier, a prolific inventor based in Basel, CH, has made significant contributions to the field of pharmaceuticals through his groundbreaking inventions. With a total of 11 patents to his name, Furlenmeier's work has greatly impacted the medical industry, particularly in the development of cephalosporin derivatives and the acylation of amines.

Latest Patents:

Furlenmeier's latest patents showcase his expertise in pharmaceutical chemistry. One notable invention is the development of Cephalosporin derivatives, which have shown promising results in the control of illnesses. These compounds, along with their esters, salts, and hydrates, have opened new possibilities in pharmacology. Additionally, his work on the acylation of amines has led to a novel process for manufacturing carboxylic acid amides, particularly beneficial for unstable amines like 7-aminocephalosporin derivatives.

Career Highlights:

As a key figure in pharmaceutical innovation, Andre Furlenmeier has made a lasting impact at Hoffmann-La Roche Inc. Furlenmeier's dedication to pushing the boundaries of pharmaceutical research has been pivotal in the company's success and reputation as a leading player in the industry. His expertise in medicinal chemistry has paved the way for new drug development and treatment options.

Collaborations:

Furlenmeier's collaborative efforts with colleagues Werner Hofheinz and Christian N. Hubschwerlen have further enriched his innovative work. Together, they have synergized their talents and knowledge to drive forward pharmaceutical advancements and enhance drug discovery processes. The fruitful collaborations among these talented individuals have resulted in cutting-edge inventions that have the potential to revolutionize the medical landscape.

Conclusion:

In conclusion, Andre Furlenmeier stands as a visionary inventor whose contributions to the field of pharmaceuticals have been nothing short of remarkable. His dedication to innovation, coupled with his collaborative spirit, underscores his commitment to advancing medical science. Furlenmeier's legacy as an inventive mind at Hoffmann-La Roche Inc. continues to inspire future generations of inventors and researchers in the pursuit of scientific excellence and breakthrough discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…